SLNO Soleno Therapeutics, Inc.
Healthcare$53.01+0.00%OpenMarket Cap: $2.76B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$80.00
Target (Median)
$80.00
Target Range
$53.00 - $107.00
Upside from current price: 50.9%
Rating Distribution
0 Strong Buy0 Buy11 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-17 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2026-04-08 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-04-07 | Wolfe Research | downgrade | Peer Perform | Outperform |
| 2026-04-07 | TD Cowen | downgrade | Hold | Buy |
| 2026-04-06 | Cantor Fitzgerald | downgrade | Neutral | Overweight |
| 2026-03-18 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-03-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-27 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-02-26 | TD Cowen | maintain | Buy | Buy |
| 2026-01-20 | Wells Fargo | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $6.14 | $687.8M | 6 |
| Sun Dec 31 | $8.85 | $982.2M | 5 |
| Mon Dec 31 | $11.42 | $1.31B | 1 |
| Tue Dec 31 | $14.32 | $1.62B | 1 |